[ad_1]
“Bad science, bad medicine and bad ethics are unproven things for influential people that they are not for ordinary people,” said Vinay Prasad, associate professor of medicine at the University of California, San Francisco.
Trump’s personal physician had previously announced that he had been administered a dose of an experimental antibody cocktail before the president was hospitalized. As a “precautionary measure,” D. Trump, 74, has been injected with a dose of synthetic antibodies from the US pharmaceutical company Regeneron.
Antibody shake therapy is currently being tested in clinical trials and is not licensed. Regeneron’s boss, Leonard Schleifer, told The New York Times that his company had “responded with great pleasure” to the White House’s request for the drug. D. Trump is not the first patient to be treated exceptionally.
A few days ago, an American company said that the first tests showed that its cocktail of intravenous antibodies could reduce the levels of the virus in the bodies of patients with Covid-19 treated in the hospital and accelerate their healing. Investigations are ongoing.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
